BALTIMORE —

Each year, more than 40,000 cancers and thousands of pre-cancers are caused by HPV.

The HPV vaccine, given to pre-teens and teens, can prevent those cancers. However, the vaccination rate remains stagnant.

Nationwide, only 63% of boys and girls ages 13-17 completed the HPV vaccination series in 2024. The goal is 80%.

The University of Maryland Greenebaum Comprehensive Cancer Center is partnering with other cancer centers to increase HPV vaccination rates.

"The message to parents is that the HPV vaccination is an incredibly effective vaccine that reduces the risk of getting any of six different types of cancers. So, vaccinating a child between the ages of 9 and 12 shows strong protection against these cancers," said Dr. Clement Adebamowo with the University of Maryland Gree

See Full Page